Preethi Korangath

9PUBLICATIONS
38CO-AUTHORS
Molecular targetsInstruments and techniquesNanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 16, 2026
Spermine Oxidase Serves as a Key Functional Node in Microbial Dysbiosis-Induced Breast Carcinogenesis.

Deeptashree Nandi, Sheetal Parida, Deepak Verma

|Nov 21, 2024
Dendritic cell activation by iron oxide nanoparticles depends on the extracellular environment.

Mason Song, Robert Ivkov, Preethi Korangath

|Jun 08, 2022
Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study.

Guannan Wang, Alok Kumar, Wanjun Ding

|Jan 11, 2021
Systemically delivered antibody-labeled magnetic iron oxide nanoparticles are less toxic than plain nanoparticles when activated by alternating magnetic fields.

Chun-Ting Yang, Preethi Korangath, Jackie Stewart

|Apr 10, 2020
For HIPEC, synergistic effects of hyperthermia and doxorubicin are optimal when simultaneously combined.

Anirudh Sharma, Michelle A Rudek, Preethi Korangath

Pageof 2